Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma

OBJECTIVES: To compare the cost-effectiveness of budesonide-formoterol in a single inhaler used as both maintenance and reliever medication versus clinician-directed titration of salmeterol-fluticasone as maintenance medication, plus salbutamol taken as needed, in controlling asthma in adults and ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth Miller, Malcolm R Sears, Andrew McIvor, Anna Liovas
Format: Article
Language:English
Published: Wiley 2007-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2007/560819
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849304602965442560
author Elizabeth Miller
Malcolm R Sears
Andrew McIvor
Anna Liovas
author_facet Elizabeth Miller
Malcolm R Sears
Andrew McIvor
Anna Liovas
author_sort Elizabeth Miller
collection DOAJ
description OBJECTIVES: To compare the cost-effectiveness of budesonide-formoterol in a single inhaler used as both maintenance and reliever medication versus clinician-directed titration of salmeterol-fluticasone as maintenance medication, plus salbutamol taken as needed, in controlling asthma in adults and adolescents.
format Article
id doaj-art-4222633442694caa9da9675dabafb27c
institution Kabale University
issn 1198-2241
language English
publishDate 2007-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-4222633442694caa9da9675dabafb27c2025-08-20T03:55:41ZengWileyCanadian Respiratory Journal1198-22412007-01-0114526927510.1155/2007/560819Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe AsthmaElizabeth Miller0Malcolm R Sears1Andrew McIvor2Anna Liovas3Axia Research Inc, CanadaFirestone Institute for Respiratory Health, St Joseph’s Healthcare, McMaster University, Hamilton, CanadaFirestone Institute for Respiratory Health, St Joseph’s Healthcare, McMaster University, Hamilton, CanadaAstraZeneca Canada Inc, Mississauga, Ontario, CanadaOBJECTIVES: To compare the cost-effectiveness of budesonide-formoterol in a single inhaler used as both maintenance and reliever medication versus clinician-directed titration of salmeterol-fluticasone as maintenance medication, plus salbutamol taken as needed, in controlling asthma in adults and adolescents.http://dx.doi.org/10.1155/2007/560819
spellingShingle Elizabeth Miller
Malcolm R Sears
Andrew McIvor
Anna Liovas
Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
Canadian Respiratory Journal
title Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
title_full Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
title_fullStr Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
title_full_unstemmed Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
title_short Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
title_sort canadian economic evaluation of budesonide formoterol as maintenance and reliever treatment in patients with moderate to severe asthma
url http://dx.doi.org/10.1155/2007/560819
work_keys_str_mv AT elizabethmiller canadianeconomicevaluationofbudesonideformoterolasmaintenanceandrelievertreatmentinpatientswithmoderatetosevereasthma
AT malcolmrsears canadianeconomicevaluationofbudesonideformoterolasmaintenanceandrelievertreatmentinpatientswithmoderatetosevereasthma
AT andrewmcivor canadianeconomicevaluationofbudesonideformoterolasmaintenanceandrelievertreatmentinpatientswithmoderatetosevereasthma
AT annaliovas canadianeconomicevaluationofbudesonideformoterolasmaintenanceandrelievertreatmentinpatientswithmoderatetosevereasthma